2.16% -0.275

Carlsmed Inc (CARL)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Carlsmed Inc Stock (CARL) Company Profile

Carlsmed Inc

Healthcare (1143)

858-295-9290

1800 ASTON AVENUE, CARLSBAD

Nächster Verdiensttermin

Neueste SEC-Einreichungen

CARL's Discussions on Twitter

Vergleichen Sie CARL mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CARL Carlsmed Inc	12.44	337.85M	0	0	0	0.00
VEEV Veeva Systems Inc	289.75	46.72B	2.97B	809.93M	1.33B	4.8743
TEM Tempus Ai Inc	89.27	14.99B	803.32M	-709.10M	-212.68M	-7.8003
DOCS Doximity Inc	66.64	12.33B	550.17M	201.35M	232.07M	1.00
HQY Healthequity Inc	94.70	8.01B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	37.27	7.09B	906.14M	-52.62M	89.62M	-0.3621

Carlsmed Inc Stock (CARL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-08-18	Eingeleitet	BTIG Research	Buy
2025-08-18	Eingeleitet	BofA Securities	Buy
2025-08-18	Eingeleitet	Goldman	Buy
2025-08-18	Eingeleitet	Piper Sandler	Overweight
2025-08-18	Eingeleitet	Truist	Buy

Carlsmed Inc Aktie (CARL) Neueste Nachrichten

Finanzdaten der Carlsmed Inc-Aktie (CARL)

Es liegen keine Finanzdaten für Carlsmed Inc (CARL) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Carlsmed Inc-Aktie (CARL) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Sidow Kevin	Director	Jul 24 '25	Buy	15.00	13,333	199,995	59,566
Mittendorff Robert II	Director	Jul 24 '25	Buy	15.00	1,333,333	19,999,995	5,013,839
ROOT JONATHAN D	Director	Jul 24 '25	Buy	15.00	466,666	6,999,990	483,999
YOUNG PHILIP M	Director	Jul 24 '25	Buy	15.00	59,999	899,985	53,333

Carlsmed Inc (CARL)

Carlsmed Inc Stock (CARL) Company Profile

Vergleichen Sie CARL mit anderen Aktien

Carlsmed Inc Stock (CARL) Upgrades & Downgrades

Carlsmed Inc Aktie (CARL) Neueste Nachrichten

Carlsmed Secures $60 Million Credit Facility Amendment - TipRanks

Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025 - The Manila Times

Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025 | User | thepilotnews.com - FinancialContent

Carlsmed, Inc.Common Stock (Nasdaq:CARL) Stock Quote - FinancialContent

Carlsmed, Inc. (NASDAQ:CARL) Short Interest Update - MarketBeat

ETFs Investing in Carlsmed, Inc. Stocks - TradingView

AI medtech firm Carlsmed prices $100.5M IPO - MSN

Earnings Preview: Carlsmed to Report Financial Results Post-market on August 28 - 富途牛牛

Carlsmed appoints Jennifer Kamocsay as CLO, secretary - MSN

People moves: Michael Kaplan rejoins StandardAero as legal chief as Jenifer Kamocsay moves over to Carlsmed - | Governance Intelligence

Carlsmed names Jennifer Kamocsay as CLO and secretary - Medical Buyer

Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary - Orthopedics This Week

Carlsmed appoints Jenifer Kamocsay as chief legal officer By Investing.com - Investing.com Nigeria

Carlsmed appoints Jenifer Kamocsay as chief legal officer - Investing.com India

Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary - GlobeNewswire Inc.

Carlsmed, Inc. Selected for Inclusion in Russell 2000 Index - 富途牛牛

Carlsmed joins Russell 2000 Index following Q3 IPO - MSN

Carlsmed announces inclusion in Russell 2000 Index - TipRanks

Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index - MarketScreener

AI-Powered Spine Surgery Innovator Carlsmed Joins $9T Russell 2000 Index Following Successful IPO - Stock Titan

Carlsmed, Inc.(NasdaqGS: CARL) added to Russell 3000E Growth Benchmark - MarketScreener

AI medtech firm Carlsmed to sell 6.7M shares in IPO - MSN

Goldman Sachs highlights two high-potential stocks: AI marketing platform Braze (BRZE.US) and medical technology company Carlsmed (CARL.US), assigning them a 'Buy' rating. - 富途牛牛

Carlsmed initiated with Buy at Truist on business potential - MSN

Carlsmed Q2 2025 revenue up 99% to USD 12.1M - Medical Buyer

Carlsmed stock rating reiterated at Buy by Goldman Sachs on growth outlook - Investing.com Australia

Carlsmed, Inc.: Strong Financial Performance and Growth Potential Justify Buy Rating - TipRanks

Carlsmed, Inc.: Strong Performance and Promising Growth Prospects with Upcoming Product Launch - TipRanks

Carlsmed Reports Strong Growth in Q2 2025 Earnings - TipRanks

Carlsmed 2025 Q2 Earnings Strong Revenue Growth Despite Widening Net Loss - AInvest

Carlsmed: A High-Growth AI-Driven MedTech Play in Spine Surgery - AInvest

UPDATECarlsmed® Reports Second Quarter 2025 Financial Results - The Manila Times

Earnings call transcript: Carlsmed’s Q2 2025 revenue surges, stock rises - Investing.com

Carlsmed Q2 Loss Narrows, Revenue Rises - MarketScreener

Carlsmed reports second quarter 2025 financial results - MarketScreener

Carlsmed® Q2 2025 Financial Performance: Assessing Long-Term Growth Potential in the AI-Driven Spine Surgery Revolution - AInvest

CARLSMED, INC. SEC 10-Q Report - TradingView

Carlsmed® Reports Second Quarter 2025 Financial Results - The Manila Times

Carlsmed, Inc.'s Q2 2025 Performance and Strategic Momentum: A Disruptive Force in AI-Driven Spine Surgery - AInvest

99% Growth: AI Spine Surgery Pioneer Carlsmed Hits $12.1M Revenue, Expands into Cervical Procedures - Stock Titan

Carlsmed CARL 2025Q2 Earnings Preview Upside Potential on AI-Driven Spine Solutions - AInvest

Two AI Small Caps Nobody Noticed - Nanalyze

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Truist Securities initiates coverage on Carlsmed stock with Buy rating By Investing.com - Investing.com Australia

Why Is Carlsmed Stock Gaining Monday?Carlsmed (NASDAQ:CARL) - Benzinga

Finanzdaten der Carlsmed Inc-Aktie (CARL)

Umsatz

Nettogewinn

Free Cashflow

ENV

Carlsmed Inc-Aktie (CARL) Insiderhandel

Ähnlich wie CARL